{"id":"W4416221617","doi":"10.1101/2025.11.12.687734","title":"NUAK2 is a therapeutically tractable regulator of RNA splicing and tumor progression in neuroendocrine prostate cancer","year":2025,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Vancouver General Hospital","funders":"Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill; European Federation of Pharmaceutical Industries and Associations; National Cancer Institute; Ontario Genomics Institute; Merck KGaA; Ontario Genomics; Genome Canada; DOD Prostate Cancer Research Program; McGill University; Genentech; Bayer; Pfizer; Duke Cancer Institute; Bristol-Myers Squibb","keywords":"Prostate cancer; RNA splicing; Spliceosome; Regulator; Tumor progression; Cancer; Mechanism (biology); Prostate; Alternative splicing; Androgen receptor","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002242254,0.000286067,0.0002532587,0.0001845701,0.0001965845,0.000405941,0.0001962908,0.0002727594,0.005355846],"category_scores_gemma":[0.0001352941,0.0001189172,0.0002075993,0.0002086194,0.0001818138,0.0002398282,0.0002096995,0.0007186617,0.001321048],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003863782,"about_ca_system_score_gemma":0.0003299007,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005067359,"about_ca_topic_score_gemma":0.0008263285,"domain_scores_codex":[0.9998854,0.00001316697,0.000004349268,0.00002776798,0.00005095579,0.00001848214],"domain_scores_gemma":[0.9999598,0.000004758654,0.00001302901,0.000005319076,0.000006422703,0.00001069637],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0004319588,0.00004271826,0.0006551127,0.0003426061,0.00003450508,0.000186311,0.00002637341,0.001433008,0.9691136,0.00299735,0.005736312,0.01900009],"study_design_scores_gemma":[0.00006613397,0.0002233363,0.003736203,0.00002844069,0.00003489808,0.0006819994,0.00003254987,0.005511934,0.9313276,0.001320271,0.05702074,0.0000158643],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.807826,0.04780326,0.07073116,0.005641615,0.001683277,0.0002343372,0.0122731,0.003469018,0.05033822],"genre_scores_gemma":[0.958759,0.007694125,0.009578865,0.0004832249,0.0001108001,0.00005312122,0.003478108,0.0001418711,0.01970108],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005355846,"threshold_uncertainty_score":0.01791704,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01729165076130216,"score_gpt":0.302044054665031,"score_spread":0.2847524039037289,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}